跳至主要内容
临床试验/CTRI/2024/03/064342
CTRI/2024/03/064342尚未招募3 期

A Comparative clinical study, to evaluate the efficacy of Haritakyadi yoga with Sarpagandha Mishrana in Essential Hypertension. - NI

DR KIRAN KUMAR BUDIHA0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Subjects fulfilling the Diagnostic criteria, for stage 1 cases of Essential Hypertension as per the guidelines of Eighth Joint National Committee.
  • 2.Freshly diagnosed and untreated case of Essential Hypertension.
  • 3.Old Cases who are on Antihypertensive medications with flush out period of 7 days.

排除标准

  • 1.Patients with Stage 2 Hypertension, SBP more than 160 and DBP more than 100 will be excluded.
  • 2.Patients with Secondary hypertension will be excluded.
  • 3.Patient with Malignant and Accelerated hypertension will be excluded.
  • 4.Hypertension associated with end organ damage such as Vasculopathies, cerebrovascular damage, Heart disease, Neuropathies and other systemic illness will be excluded.
  • 5.Patents with Uncontrolled Diabetes mellitus, RBS more than 300 mg per dl will be excluded.
  • 6.Pregnant and lactating women will be excluded.

研究者

发起方
DR KIRAN KUMAR BUDIHA

相似试验